In experimental MHC-I deficient tumor models NK cell dysfunction can be reversed by cytokines including (engineered) IL-2 and combinations of IL-12 and IL-18 which promotes tumor clearance [161, 162]. This evidence concerns the gene IL18 and neoplasm.